Home » Topics » Dermatologic, BioWorld Science

Dermatologic, BioWorld Science
RSS

ICOS initiates phase I with monoclonal antibody

April 1, 1997

Antiinflammatory compounds disclosed by Tsumura

April 1, 1997

Name change for Connective Therapeutics; patient enrollment completed in pivotal interferon trial

March 25, 1997

Additional U.S. patent issued for Cariel

March 25, 1997

Phase III results reported on finasteride for male pattern hair loss

March 24, 1997

New antiinflammatory agent from Yakult Honsha

March 24, 1997

Savage introduces nonhalogenated corticosteroid

March 24, 1997

RCT patents compounds for acne and other skin infections

March 24, 1997

Sugen's psoriasis treatment enters clinical trials

March 20, 1997

Dermagraft-TC cleared for marketing

March 20, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 17, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
Novel caspase-2 inhibitor shows in vivo neuroprotective effects
BioWorld Science
Caspase-2-mediated cleavage of tau at Asp314 generates a neurotoxic fragment, Δtau314, that drives early synaptic dysfunction in Alzheimer’s disease (AD) and...